Table 2.
Non referred group (N=220) |
Referred group (N=69) |
P value | |
---|---|---|---|
Ta at initial TURBT | |||
| |||
Number of patients | 33 | 15 | |
| |||
Residual tumor | 19(57.6%) | 10 (66.7%) | 0.210 |
| |||
Overall upstaging | 4 (12.1%) | 4 (26.7%) | 0.551 |
| |||
Upstaging to T2 | 1 (3.0%) | 0 (0%) | 0.496 |
| |||
No residual tumor | 14 (42.4%) | 5 (33.3%) | 0.210 |
| |||
T1 at initial TURBT | |||
| |||
No. of patients | 187 | 54 | |
| |||
Residual tumor | 104 (55.6%) | 47 (87.0%) | <0.001 |
| |||
Overall upstaging | 6 (3.2%) | 11 (20.4%) | <0.001 |
| |||
Upstaging to T2 | 6 (3.2%) | 11 (20.4%) | <0.001 |
| |||
No residual tumor | 83 (44.4%) | 7 (13.0%) | <0.001 |
| |||
Overall | |||
| |||
No. of patients | 220 | 69 | |
| |||
Residual tumor | 123 (55.9%) | 57 (82.6%) | <0.001 |
| |||
Overall upstaging | 10(4.5%) | 15 (21.7%) | <0.001 |
| |||
Upstaging to T2 | 7 (3.2%) | 11 (15.9%) | <0.001 |
| |||
No residual tumor | 97 (44.1%) | 12 (17.3%) | <0.001 |
TURBT: transurethral resection of bladder tumor.